Hudson Valley Investment Advisors Inc. ADV Sells 1,319 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hudson Valley Investment Advisors Inc. ADV lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 70,301 shares of the medical equipment provider’s stock after selling 1,319 shares during the period. Intuitive Surgical comprises 3.8% of Hudson Valley Investment Advisors Inc. ADV’s holdings, making the stock its 6th largest holding. Hudson Valley Investment Advisors Inc. ADV’s holdings in Intuitive Surgical were worth $34,537,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in ISRG. Creekmur Asset Management LLC boosted its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $26,000. Delos Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares in the last quarter. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction on Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,095 shares of company stock valued at $24,552,712 over the last quarter. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup increased their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Stock Performance

ISRG stock opened at $513.77 on Thursday. The company has a fifty day moving average price of $489.74 and a 200-day moving average price of $445.30. The company has a market capitalization of $182.99 billion, a P/E ratio of 82.60, a PEG ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $260.17 and a 52-week high of $523.34.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.